Taro Pharmaceutical Industries Ltd (NYSE:TARO)
$ 42.3 0.1 (0.24%) Market Cap: 1.59 Bil Enterprise Value: 737.73 Mil PE Ratio: 34.67 PB Ratio: 0.89 GF Score: 69/100

Q4 2019 Taro Pharmaceutical Industries Ltd Earnings Call Transcript

May 23, 2019 / 12:00PM GMT
Release Date Price: $94.65 (-7.13%)
Operator

Good day, ladies and gentlemen, and welcome to the Taro Pharmaceuticals Year-End 2018/'19 Earnings Call. (Operator Instructions) As a reminder, this call is being recorded.

I would now like to turn the call over to William Coote. You may begin

William J. Coote
Taro Pharmaceutical Industries Ltd. - Assistant VP of Business Finance & IR and Treasurer

Thank you. Good morning, everyone, and welcome to our 2018/'19 year-end earnings conference call. Joining me today on the call are Mr. Dilip Shanghvi, Chairman of the Board of Directors; Mr. Uday Baldota, Taro's CEO; and Mariano Balaguer, CFO. We hope you received the copy of the earnings press release, which can be found on our website at taro.com.

We anticipate that many of you may have questions concerning not only this quarter's and full year financial performance, but also other markets, operations, strategies and other matters. While we try to respond to most of your queries, we will not be able to share product specific and commercially sensitive information, including pipeline details.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot